Work

A comparative safety analysis for durvalumab in patients with locally advanced, unresectable NSCLC: PACIFIC versus pooled durvalumab monotherapy studies.

Year: 2018

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2018.36.15_suppl.8556

Authors: Scott Joseph Antonia, Matthew David Hellmann, Phillip A. Dennis, Giovanni Melillo, Shaad Essa Abdullah, Andrew Lloyd, Naiyer A. Rizvi

Institutions: Moffitt Cancer Center, Memorial Sloan Kettering Cancer Center, AstraZeneca (United Kingdom), Columbia University Irving Medical Center

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2889562329

Cites:

Cited by: 2

Related to: 10